JP2008540557A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540557A5
JP2008540557A5 JP2008511333A JP2008511333A JP2008540557A5 JP 2008540557 A5 JP2008540557 A5 JP 2008540557A5 JP 2008511333 A JP2008511333 A JP 2008511333A JP 2008511333 A JP2008511333 A JP 2008511333A JP 2008540557 A5 JP2008540557 A5 JP 2008540557A5
Authority
JP
Japan
Prior art keywords
group
ether group
ether
compound represented
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008511333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540557A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/018153 external-priority patent/WO2006122216A2/en
Publication of JP2008540557A publication Critical patent/JP2008540557A/ja
Publication of JP2008540557A5 publication Critical patent/JP2008540557A5/ja
Pending legal-status Critical Current

Links

JP2008511333A 2005-05-11 2006-05-11 フェノール型4−ビフェニリルアゼチジン−2−オンの製造方法 Pending JP2008540557A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67978505P 2005-05-11 2005-05-11
PCT/US2006/018153 WO2006122216A2 (en) 2005-05-11 2006-05-11 Processes for production of phenolic 4-biphenylylazetidin-2-ones

Publications (2)

Publication Number Publication Date
JP2008540557A JP2008540557A (ja) 2008-11-20
JP2008540557A5 true JP2008540557A5 (https=) 2009-08-13

Family

ID=37397290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511333A Pending JP2008540557A (ja) 2005-05-11 2006-05-11 フェノール型4−ビフェニリルアゼチジン−2−オンの製造方法

Country Status (15)

Country Link
US (1) US20080200669A1 (https=)
EP (1) EP1885703A4 (https=)
JP (1) JP2008540557A (https=)
KR (1) KR20080017345A (https=)
CN (1) CN101218213A (https=)
AU (1) AU2006244043A1 (https=)
BR (1) BRPI0608970A2 (https=)
CA (1) CA2608075A1 (https=)
EA (1) EA200702464A1 (https=)
IL (1) IL187287A0 (https=)
MA (1) MA29539B1 (https=)
MX (1) MX2007014172A (https=)
NO (1) NO20076371L (https=)
WO (1) WO2006122216A2 (https=)
ZA (1) ZA200710721B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AU2004288822A1 (en) * 2003-11-10 2005-05-26 Microbia, Inc. 4-Biarylyl-1-phenylazetidin-2-ones
EP1699759B1 (en) 2003-12-23 2010-10-20 AstraZeneca AB Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
TW200726746A (en) * 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones
JP2008543744A (ja) * 2005-05-09 2008-12-04 マイクロビア インコーポレーテッド 有機金属ベンゼンホスホナートカップリング剤
EA200702614A1 (ru) * 2005-05-25 2008-04-28 Майкробиа, Инк. Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
JP2010500300A (ja) 2006-08-08 2010-01-07 サノフィ−アベンティス アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
WO2010113184A1 (en) * 2009-04-02 2010-10-07 Lupin Limited Kinetic resolution of (4s)-4-phenyl-3-[5(rs)-(4-fluorophenyl)-5-hydroxypentanoyl] -1,3 oxazolidin 2-one to (5s) isomer via lipase catalyzed enantioselective esterification of the (5r) isomer
MX2012001729A (es) 2009-08-26 2012-06-13 Sanofi Sa Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
CN102285932B (zh) * 2011-09-01 2013-06-12 浙江大学 一种依替米贝中间体的制备方法
KR102919209B1 (ko) 2018-08-10 2026-01-28 다이아핀 테라퓨틱스, 엘엘씨 트리-펩타이드 그리고 대사, 심장혈관 및 염증성 장애의 치료

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107548T3 (es) * 1991-07-23 1997-12-01 Schering Corp Compuestos de beta-lactama sustituidos utiles como agentes hipocolesterolemicos y procedimientos para su preparacion.
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
HK1039487B (en) * 1998-12-07 2005-08-12 Merck Sharp & Dohme Corp. Process for the synthesis of azetidinones
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
HRP20030498A2 (en) * 2000-12-21 2005-04-30 Aventis Pharma Deutschland Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
EE05453B1 (et) * 2001-03-28 2011-08-15 Schering Corporation Protsess asetidinoonvahehendite valmistamiseks
WO2004099132A2 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Process for the preparation of trans-isomers of diphenylazetidinone derivatives
AU2004288822A1 (en) * 2003-11-10 2005-05-26 Microbia, Inc. 4-Biarylyl-1-phenylazetidin-2-ones
WO2006116499A1 (en) * 2005-04-26 2006-11-02 Microbia, Inc. 4-biarylyl-1-phenylazetidin-2-one glucuronide derivatives for hypercholesterolemia
US20090131395A1 (en) * 2005-05-05 2009-05-21 Microbia, Inc. Biphenylazetidinone cholesterol absorption inhibitors
TW200726746A (en) * 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones

Similar Documents

Publication Publication Date Title
JP2008540557A5 (https=)
JP2008545700A5 (https=)
JP2004536811A5 (https=)
JP2003520235A5 (https=)
JP2010510976A5 (https=)
JP2011500769A5 (https=)
JP2007511546A5 (https=)
JP2006509046A5 (https=)
JP2009538336A5 (https=)
JP2013520495A5 (https=)
JP2007524706A5 (https=)
JPWO2021030554A5 (https=)
JP2004504323A5 (https=)
JP2008542205A5 (https=)
JP5115477B2 (ja) 水酸基を有する3−エチルオキセタン化合物及びその製法
US20150057462A1 (en) Methods of preparing low molecular weight carbosilanes and precursors thereof
JP2008526897A5 (https=)
JP2008520662A5 (https=)
JP2006514956A5 (https=)
JP2004018831A5 (https=)
JP2004010877A5 (https=)
JP2011513358A5 (https=)
JP2006512470A5 (https=)
JP5257353B2 (ja) 置換ヒドロキシメチルフェノールの新規な合成
JP2007513070A5 (https=)